nib Holdings Ltd:企業の戦略・SWOT・財務分析

◆英語タイトル:nib Holdings Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5372
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥24,850見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥49,700見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥74,550見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

nib Holdings Ltd – Strategy, SWOT and Corporate Finance Report
Summary

nib Holdings Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

nib Holdings Ltd (nib Holdings) is a health insurance company. The company, along with its principal subsidiaries, offers a wide range of insurance products and services primarily across the Australian health insurance sector. It offers health insurance policies for individuals, couples, families, and employees. The company also offers life insurance products which include value life insurance and income protection plans. Furthermore, it distributes travel insurance policies to its customers. The company has operations in Australia and New Zealand. nib Holdings is headquartered in Newcastle, New south Wales, Australia.

The company reported premium revenue of AUD2,372.6 million during fiscal year ended June 2019 (FY2019), an increase of 8.5% over that in FY2018. Its net premium revenue was AUD2,340.8 million in FY2019, an increase of 8.2% over that in FY2018.

Scope

- Detailed information on nib Holdings Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting nib Holdings Ltd in the form of a SWOT analysis
- An in-depth view of the business model of nib Holdings Ltd including a breakdown and examination of key business segments
- Intelligence on nib Holdings Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about nib Holdings Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of nib Holdings Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess nib Holdings Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on nib Holdings Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
nib Holdings Ltd: Company Overview
nib Holdings Ltd: Overview and Key Facts
nib Holdings Ltd: Overview
nib Holdings Ltd: Key Facts
nib Holdings Ltd: Key Employees
nib Holdings Ltd: Key Employee Biographies
nib Holdings Ltd: Major Products and Services
nib Holdings Ltd: Company History
nib Holdings Ltd: Management Statement
nib Holdings Ltd: Locations and Subsidiaries
nib Holdings Ltd: Key Competitors
nib Holdings Ltd: Company Analysis
nib Holdings Ltd: Business Description
nib Holdings Ltd: SWOT Analysis
nib Holdings Ltd: SWOT Overview
nib Holdings Ltd: Strengths
nib Holdings Ltd: Weaknesses
nib Holdings Ltd: Opportunities
nib Holdings Ltd: Threats
nib Holdings Ltd: Corporate Financial Deals Activity
nib Holdings Ltd: Financial Deals Overview
nib Holdings Ltd: Targets and Partners
nib Holdings Ltd: Top Deals 2016 – 2020YTD*
nib Holdings Ltd: Advisors
nib Holdings Ltd: Top Legal Advisors
nib Holdings Ltd: Top Financial Advisors
nib Holdings Ltd: Mergers and Acquisitions
nib Holdings Ltd: Capital Raising
nib Holdings Ltd: Partnership
nib Holdings Ltd: Recent Developments
nib Holdings Ltd: News and Events Summary
nib Holdings Ltd: Corporate Governance
nib Holdings Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: nib Holdings Ltd: Key Facts
Table 2: nib Holdings Ltd: Key Employees
Table 3: nib Holdings Ltd: Company History
Table 4: nib Holdings Ltd: Locations and Subsidiaries
Table 5: nib Holdings Ltd: Key Competitors
Table 6: nib Holdings Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: nib Holdings Ltd: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: nib Holdings Ltd: M&A Average Deal Size - Value (US$m)
Table 9: nib Holdings Ltd: Targets and Partners
Table 10: nib Holdings Ltd: Top Deals 2016 - 2020YTD*
Table 11: nib Holdings Ltd: Legal Advisor Ranking by Value (US$m)
Table 12: nib Holdings Ltd: Financial Advisor Ranking by Value (US$m)
Table 13: nib Holdings Ltd: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: nib Holdings Ltd: M&A Activity by Geography (2016 - YTD*2020)
Table 15: nib Holdings Ltd: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 16: nib Holdings Ltd: Capital Raising by Deal Type (2016 - YTD*2020)
Table 17: nib Holdings Ltd: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 18: nib Holdings Ltd: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 19: nib Holdings Ltd: News and Events Summary
Table 20: nib Holdings Ltd: Corporate Governance
Table 21: nib Holdings Ltd: Strategy and Operations

★海外企業調査レポート[nib Holdings Ltd:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alliance Pharma Plc (APH):製薬・医療:M&Aディール及び事業提携情報
    Summary Alliance Pharma Plc (Alliance) is a specialty pharmaceutical company. It focuses on acquisition, licensing, registration and marketing of pharmaceutical products. It promotes acquired and licensed prescription products across various therapeutic categories such as dermatology, central nervou …
  • Barilla Holding S.p.A.:企業の戦略・SWOT・財務情報
    Barilla Holding S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Barilla Holding S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Jubilant Life Sciences Ltd (JUBILANT):製薬・医療:M&Aディール及び事業提携情報
    Summary Jubilant Life Sciences Ltd (Jubilant) is an integrated pharmaceutical and life sciences company that provides pharmaceuticals, life science ingredients and drug discovery solutions. The company’s product portfolio includes radiopharmaceuticals, allergy therapy products, active pharmaceutical …
  • Prologis, Inc.:企業の戦略・SWOT・財務情報
    Prologis, Inc. - Strategy, SWOT and Corporate Finance Report Summary Prologis, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Lake Country Power:企業の戦略的SWOT分析
    Lake Country Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Carbon Energy Corp (CRBO):石油・ガス:M&Aディール及び事業提携情報
    Summary Carbon Energy Corp (Carbon Energy), formerly Carbon Natural Gas Company is an independent oil and gas company. The company operates in the exploration, operation, management, and development of oil and gas properties in the Appalachian and Illinois Basin regions of the US. It holds interests …
  • Nuvo Pharmaceuticals Inc (NRI)-製薬・医療分野:企業M&A・提携分析
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly known as Nuvo Research Inc is a drug company that offers topical pain products and technologies. The company’s product portfolio includes pennsaid, pennsaid 2%, and heated lidocaine and tetracaine patches. Its products deliver drugs topically into an …
  • IDOX Plc (IDOX):企業の財務・戦略的SWOT分析
    Summary IDOX Plc (IDOX) operates as an information technology company that supplies and develops software solutions and information services. The company offers services such as funding, manages services, government and compliance solutions. Its government services include environmental, legal, demo …
  • CEL-SCI Corp (CVM):製薬・医療:M&Aディール及び事業提携情報
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Societe Generale S.A.:企業の戦略・SWOT・財務情報
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • TheraDiag SA (ALTER):医療機器:M&Aディール及び事業提携情報
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • Bailian Group Co Ltd:企業の戦略的SWOT分析
    Bailian Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Cosmo Pharmaceuticals NV (COPN)-医療機器分野:企業M&A・提携分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix (MMX) technology. Its proprietary clinical development pipeline intended for the treatm …
  • Carlisle Companies Incorporated:企業のM&A・事業提携・投資動向
    Carlisle Companies Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Carlisle Companies Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • McConnell Dowell Corp Ltd:企業の戦略的SWOT分析
    McConnell Dowell Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Transelectrica SA:企業の発電所・SWOT分析2018
    Transelectrica SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Mologen AG (MGN):企業の財務・戦略的SWOT分析
    Summary Mologen AG (Mologen) is a biotechnology company that offers research and clinical development of novel drugs, immunotherapies and active ingredients. The company develops various pipeline products such as MGN1703, MGN1601, MGN1404, MGN1331 and MGN1333. It uses proprietary platform technologi …
  • Elecnor SA (ENO):電力:M&Aディール及び事業提携情報
    Summary Elecnor SA (Elecnor) is an engineering and construction company. It specializes in engineering, development and construction of projects relating to infrastructure, renewable energies and new technologies. The company focuses on end-to-end management of electricity, power generation, telecom …
  • Helomics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Helomics Corp (Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • Hite Jinro Co., Ltd:企業の戦略・SWOT・財務情報
    Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆